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Abstract 
 Chapter 1: 
 Cholesteatoma is a middle ear disease characterized by a cystic lesion that grows 
from the tympanic membrane. There are several theories as to the cause of the disease, 
though the most prominent cause is eustachian tube dysfunction. Using an animal 
model to characterize the disease and develop a method for surgical eradication is a 
novel research area as most often animal models are used to describe the disease and the 
damage caused to the middle ear by the disease. Medical intervention is solely surgical, 
so an animal model to explore intervention and reconstruction techniques would be a 
valuable resource, which is the focus of this study. 
Chapter 2: 
 A cholesteatoma anima was developed in chinchillas by injecting propylene 
glycol through the tympanic membrane and into the middle ear cavity, at concentrations 
of 70 and 90%. The disease developed for 2-6 weeks to achieve different levels of 
severity. Hearing function tests were used to compare hearing levels before and after 
inoculation. At the end of the inoculation time course, the cholesteatoma was eradicated 
surgically. Animals that survived surgery recovered for two weeks, and final hearing 
levels were measured. One animals that survived surgery was imaged with micro-CT. 
Also, three animals were euthanized early in the study at one, two, and four weeks for 
three different cholesteatoma levels.  
Chapter 3: 
 In this pilot study, a primary outcome is the method for building the disease 
model in chinchillas. Also, a method for surgical intervention and reconstruction has 
xii 
been developed for chinchillas. Hearing measurements including wideband 
tympanometry and auditory brainstem response were taken before inoculation, after the 
disease time course, and after surgical intervention, though only one animal had 
measurable results for each measurement point; some hearing recovery after 
reconstruction was measured. Histology images show the results of different inoculation 
time frames, providing a basis for a classification of this animal model’s disease states. 
Finally, micro-CT images taken after recovery show the damage in the middle ear due 
to cholesteatoma.   
Chapter 4: 
 Based on endoscopic photographs, histology sections, and micro-CT scans, a 
characterization of cholesteatoma growth has been developed with three levels of 
severity: mild, moderate, and severe. Hearing function recovery in chinchillas has been 
demonstrated, though significant improvement in surgical reconstruction is required for 
future studies.  
Chapter 5: 
 Preliminary results suggest a that these methods will results in cholesteatoma 
models at different levels by controlling time, propylene glycol concentration, and 
inoculation volume, though the greatest factor is time. This should be later verified with 
larger studies for statistical analysis. Cholesteatomas can be surgically removed from 
chinchillas and hearing function can be regained after reconstruction. Future studies 
should include disease specific prosthesis to enhance hear recovery.  
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Chapter 1: Cholesteatoma – A Middle Ear Disease 
Cholesteatoma is a middle ear disease characterized by a keratinizing cystic 
lesion of the tympanic membrane and can be found in patients young and old. A 
diagram of the ear with a cholesteatoma is shown in Fig. 1. Generally, reoccurring 
middle ear infection and eustachian tube dysfunction have been attributed to be a main 
cause of the disease and has been studied in some animal models. The disease has been 
an interest of study and therapy since the 19th Century. Only recent advances in 
imaging, biochemistry, and physiology have enabled better understanding of the 
disease’s pathogenesis. In this study, a cholesteatoma animal model was developed in 
chinchillas to determine factors that influence disease severity and to develop a method 
for surgical eradication and reconstruction.   
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Figure 1. Left ear with cholesteatoma growing in the attic of the middle ear behind 
the TM (from www.betterhealth.vic.gov)   
 
This work is divided into five chapters: Chapter 1 details past research of the 
disease including origin theories, disease growth and complications, clinical treatment, 
and recent animal models with the purpose of the current research to conclude. Chapter 
2 describes how propylene glycol injections were used to create the used animal model; 
Chapter 3 reports the results of the research; Chapter 4 discusses the results with 
commentary; Chapter 5 is the future direction of the research to be explored.  
Theories of Causes 
To clarify, cholesteatoma has two types of origins: acquired and congenital. We 
only consider acquired in this research and will not elaborate extensively on the latter. 
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To note the key difference, congenital cholesteatomas are developed pre-natal, likely 
during the ear’s formation. However, it may be difficult to diagnose patients with 
congenital cholesteatoma due to a lack of diagnostic criteria (Lee and Park, 2011). 
Congenital cholesteatoma may be easier to treat with a lower reoccurrence rate (Ching 
et al 2016). H.-G. Choi et al. suggested the need for acquired and congenital to be 
treated differently and called for rapid treatment upon discovery of congenital 
cholesteatoma to limit life-long damage (Choi et al 2010). Acquired, on the other hand, 
develops due to disease, infection, tympanic membrane (TM) damage, or other means, 
which will be discussed here. 
  Etiopathogenesis of acquired cholesteatoma has four prominent theories in 
literature, though it is generally accepted that reoccurring middle ear infections and 
eustachian tube dysfunction are the main causes of the disease. Four theories have been 
used to describe in detail how cholesteatomas form: invagination, epithelial migration, 
squamous metaplasia, and basal cell hyperplasia. Figure 2 is a useful diagram for 
visualizing these theories. For a broad overview of etiopathogenesis, both Kuo (2015) 
and Olszewska et al (2003) provide detailed reviews of the state of research and 
knowledge of the disease. 
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Figure 2. Visualization of the four prominent cholesteatoma theory pathways: 1) 
Invagination/retraction pocket theory, B) Epithelial migration theory, C) Squamous 
metaplasia theory, and D) Basal cell hyperplasia theory. (Kuo, 2015)   
   
Invagination/retraction pocket theory is widely accepted and was proposed in 
1933 (Wittmaack 1933). The pars flaccida is gradually pulled into the middle ear due to 
negative pressure (Fig. 1A), which can be caused in several ways. The pocket deepens, 
begins accumulating desquamated keratin and eventually an inward growing 
cholesteatoma. To test this theory, cholesteatoma patients who habitually sniffed were 
compared to cholesteatoma patients who did not (Takizawa et al 2013). Of patients with 
cholesteatomas, those who were habitual sniffers had higher occurrence and 
reoccurrence rates compared to those with normal sniffing patterns. Sniffing pulls in the 
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TM due to negative pressure caused by frequent opening and closing of the eustachian 
tube and could produce the disease readily.  
 Epithelial migration theory is a second possible method of etiopathogenesis 
(Habermann 1888; Bezold 1890). The theory suggests that cholesteatoma may occur 
when a TM has been injured (Fig. 1B). Keratinizing squamous epithelium migrates 
from the ear canal through the TM. The migration causes an inward tumor-like growth, 
thus creating a cholesteatoma.  
 A third theory is the squamous metaplasia theory (Wendt 1873).  This theory 
contradicts the previous in that cholesteatoma growth originates in the middle ear 
mucosa rather than the external TM (Fig. 1C). Inflammation and growth in the middle 
ear could cause TM perforation as seen in otoscopic examination. However, this theory 
has been mostly shown to be inaccurate by many animal models and studies.  
 The last theory is the basal cell hyperplasia theory (Lange 1925). Subepithelial 
tissue could be invaded by cholesteatoma microcysts within pars flaccida (Fig. 1C). 
Keratin-filled microcysts are formed in the basal layer of the epithelium. Given enough 
time, cholesteatoma sacs will form in these conditions. This theory does not necessarily 
contradict the retraction pocket or migration theory, but proposes that cholesteatoma 
formation may be possible without the insults observed in the latter two.  
 Though many animal models test individual theories, it seems that each theory 
has shown validity at some level. Early cholesteatoma is dependent on TM retraction in 
most cases, though this does not limit the necessity of other factors (Rosito et al 2017). 
This would suggest a plurality of causes of the disease rather than a single underlying 
mechanism. If this is the case, the disease may prove more difficult to cure and prevent 
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than if a single theory was shown to dominate. There could be four methods that will 
cause the disease or even a mix of more than one. Developing a robust treatment or 
preventative diagnosis would thus be increasingly complex.  
 Some examination into cholesteatoma’s heritability determined that the genetics 
is not a primary contributor to the disease onset (Jennings et al 2017). In their synthesis, 
there were some cases of primary relatives showing similar disease onset and 
occurrence. Overall, though, there was not a strong genetic correlation. It could be that 
genetic ear development factors may contribute to congenital cholesteatoma growth, but 
a more refined review would be required.    
 
Progression of the Disease 
A model used to study the development of the disease in vivo, though out of the 
ear, was developed by Bretlau et al (1979). In nude mice, transplanted cholesteatomas 
were placed beneath hind epithelial and allowed to grow. Compared to jaw keratocyst, 
they developed cystic lesions lined by stratified keratinizing epithelium with weak 
connective tissue reaction. They believed their method would be useful for studying 
regulatory factors over differentiation and growth. Compared to cholesteatoma found in 
the middle ear, their growths were histologically comparable. 
External ear canal cholesteatomas are another form of the cholesteatoma 
disease. Rather than originating in the middle ear cavity, the disease develops in the 
external ear canal, and can extend inward, backward, or forward, damaging similar 
features as middle ear cholesteatoma (Chen et al. 2007). External ear canal 
cholesteatoma can damage periosteum bones near the ear canal, or push inward to the 
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middle ear cavity, damaging the ossicles and, if left untreated for long durations, the 
cochlea. 
In the natural setting of the middle ear cavity, cholesteatomas may grow slowly 
and unnoticed. In one case, a 52-year-old did not seek treatment for his ear problem 
even after a year of noticing it, describing it as a fullness (House and Sheehy, 1980). 
Others in the study by House and Sheehy claimed that symptoms were present for more 
than five years before seeking treatment, suggesting that the disease began developing 
much sooner. They also suggest that in the case of the intact TMs, the disease may be 
congenital rather than acquired, with some patients experiencing the disease for 20 
years. 
Bone Erosion, Ossicular Damage, Hearing Loss 
If left untreated, cholesteatoma can cause extensive and irreparable damage to 
the ear, effecting hearing, overall health, and the quality of life in patients. Serious 
complications include facial palsy, vestibular disorder, meningitis, intracranial 
abscesses, and sigmoid sinus thrombis (Cosgarea et al 2011). The disease is known to 
cause damage to the middle ear by disjoining the ossicular bones and eroding them, 
eroding the middle ear walls including the cochlea, destroying the tympanic membrane, 
and in conjunction with other diseases can damage the eustachian tube. A concern is the 
time it can take for patients to notice a problem and acting on thereupon will take 
longer.  
 Erosion (or resorption) of the bony walls has been studied extensively. Theories 
as to the cause of erosion included: 1) pressure necrosis, 2) chronic osteomyelitis,  
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3) osteoclastic osteolysis, 4) ostocytic osteolysis, 5) mocyte-mediated resorption, 6) 
enzyme-mediated resorption, 7) local pH change, and 8) vascular proliferation.  
 In an extensive review, Abramson and Huang explored bone resorption and 
destruction due from cholesteatoma due to collagenase (1973). Their key discussions 
showed that collagenase, which makes up 90% of the protein in bone, is found in 
cholesteatoma, canal wall skin, and middle ear granulation tissue; collagenase was 
found in subepithelial connective tissue and dermis but not epithelial debris; 
collagenase originates from macrophages, epithelial-appearing fibroblasts, and 
endothelial cells of capillary buds; collagenase is specifically localized to initiate 
collagen degradation in connective tissue and bone. Their point was to study the 
interaction of events and determine the cause of bone resorption in the presence of 
cholesteatoma. However, due to the complex interaction, they could only determine the 
presence of some conditions (collagenase within cholesteatoma) and the outcomes 
(extensive bone resorption), but they could not determine the specific mechanism 
behind cholesteatoma caused bone destruction.  
Marci et al tested whether pressure of the cholesteatoma bulge was enough to 
cause erosion or if contact between the sac and the bony wall was necessary (Marci et al 
1983). Barriers placed between a cholesteatoma and the bony wall does not prevent 
erosion. Furthermore, they described the bone erosion mechanism as a local release of 
lymphokine, osteoclast-activating factors due to pressure. They suggested that halting 
the pressure of the disease may prevent bone erosion. Other research in signaling 
pathways has specified TRM-2 modulating the TLR4 signal pathway enhances 
inflammatory response, promoting matrix metalloproteinases secretion and osteoclast 
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activation (Jiang et al 2016). This could provide a target of treatment, limiting the bone 
destruction. 
 However, more than halting pressure is needed to limit bone erosion. Kaneko et 
al found that the contents within the cholesteatoma sac, when divulged, could cause 
erosion. The subepithelial layers contained in the sac fixated to the bony walls and an 
eroding process had begun. As such, there are more factors that affect bone erosion than 
just pressure. Xie et al provide an updated review of the current knowledge of bone 
resorption and its role in the etiopathogenesis of cholesteatoma (2017).  
 
Evaluation of Severity 
 Perhaps the greatest frustration apart from treating the disease is implementing a 
widely accepted classification and staging system to the disease. Even consistently 
using the same vernacular has been slow to be accepted when a 1964 Committee of 
Conservation of Hearing published a detailed classification (1965). Modern literature 
has perhaps progressed in consistency with the diction used, though classifications have 
become numerous.  
 A classification system was attempted by Meyerhoff and Truelson (1986). They 
realized that even with thorough surgical reports on numerous cases, not describing the 
conditions and rationale behind surgical choices would inhibit other otologists. Their 
system was a table that could describe the type, location, function of eustachian tube, 
ossicular chain integrity, and complications that unfolded. The goal was to encourage 
literature reporting that could be interpreted easily and to standardize the nomenclature.
 Saleh and Mills developed a staging system based off a previous classification 
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system by Tos (Tos et al 1988; Saleh and Mills 1999). Their staging system was based 
on origination, degree of the disease spread, complications and, state of the ossicular 
chain.  A cholesteatoma originating in the attic, spreading to 2 other locations, with an 
eroded incus, and no complication would be labeled as (A S2 O1 C0). Their goal would 
be to provide a simple and fast description of the disease for literature to correlate 
cholesteatoma severity and the surgery used to cure it.  
 The Japanese Otological Society proposed a staging system for types of 
cholesteatoma based on the acquired location, either pars flaccida or pars tensa 
(Matsuda et al 2018). Their staging system informs on the disease involvement with 
three stages: Stage I indicates the disease resides at the primary site; Stage II, the 
cholesteatoma involves two or more sites; Stage III involves sites of any number with 
complications. There are several complications, all abbreviated with letters, and 
includes operative procedures depending on the stapes involvement. Their staging 
system should help surgeons readily understand the disease severity along with the 
surgery process used to clear it. Furthermore, patients can be better informed about their 
condition and operation procedures. 
Clinical Treatment 
Currently, surgery is the only option for removing the disease. The surgery is 
often mildly invasive, depending on the level of disease severity. Surgeons must lift and 
circumvent the tympanic membrane to reach the middle ear cavity. The disease is then 
excavated through suction and scraping. The bony walls are likely littered with the 
proliferating squamous epithelial cells, so the bony middle ear cavity (MEC) is 
thoroughly scraped to increase the chances of the disease not returning. The main 
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purpose of surgery is to eradicate the disease to avoid further complications and to 
restore hearing if possible. In review of surgical reports, only 58% of patients showed 
improved hearing conditions and no improvement in 23% (Cosgarea et al 2011). 
Furthermore, 28% of those patients required a second intervention due to recurrence of 
the disease. Improved imaging, planning, surgical techniques, and treatments are needed 
on an individual patient level to improve the outcomes of the populace effected by the 
disease.  
Surgical planning has been advanced with the use of different spectroscopes. 
Using coherent anti-Stokes Raman spectroscopy microendoscope, cholesteatoma was 
differentiated from inflammatory tissue (Zou et al 2016). The visualization could enable 
better surgical planning prior to the surgery, a critical component to eradication success. 
Tools such as CT scans have assisted physicians in assessing cholesteatoma and 
performing surgeries (Razek et al. 2015, Chen et al 2017). Razek et al. showed the 
location, size, and severity of the disease can be determined using the imaging, after 
which appropriate surgical procedures can be carried out. Chen et al. also used CT scans 
to diagnose external ear canal cholesteatomas. Imaging techniques have shown to be 
useful, enhancing the rate of surgical success and accurately assessing the disease 
before surgery takes place. 
There are three main approaches used for surgical eradication: tympanoplasty, 
canal wall-down mastoidectomy, and canal wall-up mastoidectomy (Shohet and Jong 
2002). Radical mastoidectomy, where the TM and ossicles are not reconstructed and the 
eustachian tube is sealed is rare, especially in the pediatric population. The different 
surgery approaches are decided by the extent of the disease. For TM residing 
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cholesteatoma, tympanoplasty is an excellent option. Canal wall-up is used for less 
extensive cholesteatomas than canal wall-down and provides flexibility for different 
hearing aid inserts if necessary. Canal wall-down provides a greater visual area and is 
used for more extensive operations. All operations are accompanied by a 6 month 
follow-up and possible reentry to clear the disease.  
Often some level of ossicular reconstruction is required. As mentioned, the 
disease is accompanied by high amount of erosion. The malleus and incus are generally 
damaged or destroyed in the disease progression; the stapes has been found to be 
damaged, though this occurs less often. Its tolerance to the disease is likely due to both 
its location and its density. Furthest from the tympanic membrane and, as far as the 
middle ear ossicles are concerned, the stapes would be the last to be affected by the 
diseases progression. Both cases have been seen, though, and are handled only slightly 
differently.  
Two primary types of prosthesis are used: partial ossicular replacement 
prosthesis (PORP) and total ossicular replacement prosthesis (TORP).  There is a large 
number of more specific designs that will not be discussed. In general, a large disk 
connected to the TM or facia replacement will have a fixed strut that can connect to the 
stapes head or footplate. The main difference between PORPs and TORPs is the length 
of the strut. PORPs will fix to the stapes head while TORPs may fix to the footplate of 
the stapes. 
In hope of determining a non-surgical cure for the disease, the disease pathway 
has been studied extensively. Research on the proliferation signal pathways of acquired 
cholesteatoma were reviewed by Xie et al (Xie et al 2016). Their review consolidates 
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and describes the collectively understood etiopathogenesis. However, the state of the art 
research has not progressed therapies of the disease yet, even with detailed knowledge 
of the proliferation pathways. As well, intercellular communication between 
keratinocytes and fibroblasts was determined to be an important function of 
differentiation and osteoclast in cholesteatoma, directly tied to bone destruction 
(Iwamoto et al 2015). Exploiting this communication could provide a means for 
preventing bone destruction, though not necessarily in the growth of the disease.   
Recent Research and Animal Models 
Animal models using various methods have been used to create and study 
cholesteatoma. Guinea pigs, chinchillas, rats, Meriones unguiculatus, and Mongolian 
gerbils have all been used. As mentioned, nude mice were used to grow cholesteatomas 
outside the middle ear to study the differentiation and growth factors of the disease 
(Bretlau et al 1981). Yamamoto-Fukunda et al provide a recent and thorough review of 
cholesteatoma animal models (Yamamoto-Fukunda et al 2011). Their review mostly 
discusses animal models that have been used to test theories of cholesteatoma genesis. 
They usefully categorize the methods used to produce cholesteatoma and detail which 
theory is tested, which species the method has been used in, difficulty of surgery, rate of 
success, and the advantages of the model.   
 An early animal model using chinchillas was developed using topical otic 
preparations, a cortisporin otic suspension (Wright et al 1984). The animals were 
studied between four days and five months, with most animals past two month 
developing cholesteatomas. Extensive erosion was observed, further likening it that of 
the human disease. Most of the cholesteatomas were observed as a result of tympanic 
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membrane and external ear canal damage, a form of epidermal migration. This study 
using chemical methods of producing the disease has been critical to future studies, 
especially with the identification of propylene glycol heavily contributing to 
inflammation of the middle ear.   
 Exploring the migration theory of cholesteatoma, Hueb et al inserted chemically 
modified gelatins through perforated TMs in chinchillas (1993). The staged the animals 
at 8, 10, and 12 weeks, used histology to assess the cellular composition and assess the 
extent of cholesteatoma. Their procedure was most successful in the 8 and 10 weeks, 
with a 60% and 80% success respectively. However, the 12 weeks animals had 
absorbed the gelatin packs and there was a 20% success. For their model, they found 
these parameters to be critical to cholesteatoma formation: TM perforation, middle ear 
inflammation, stimulation of epithelial cell migration, and a bridge connecting the TM 
and the inflammatory process. They believe that the cells forming the cholesteatoma 
originated from the ear canal rather than the tympanic membrane, supporting the 
migration theory. 
 Drugs to inhibit cholesteatoma formation and encourage tympanic membrane 
healing have been studied in animals. As an established animal model, chinchillas were 
used to study the effects of hyaluronic acid after propylene glycol inoculations (White 
et al 1995). Limiting the proliferation of epithelial of the TM after PG injection could 
prevent cholesteatoma formation. However, the several factors that contribute to its 
formation proved that treating a symptom would not prevent the disease, and the 
hypothesis was disproven. There was no significant effect of the drug on the TM. 
However, in the study, the authors do not report perforating or damaging the TM nor 
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was the ear canal a main contributor to the disease. Their method of disease growth 
would cause cholesteatoma formation in a way similar to that of congenital rather than 
acquired, which occurs under different conditions. 
 Gerbilline were used to determine main contributors to spontaneous 
cholesteatoma after otitis media with effusion (Omura et al 1995). With cauterized 
eustachian tubes, their experiment simulated dysfunction of the eustachian tube, linked 
to causing cholesteatoma. Epidermal growth factors were present at high levels in the 
disease cases, present in biochemical changes in the TM, mucous layer, and lamina 
propria. Likely epidermal growth factors contribute significantly to the proliferation and 
progression of the disease in clinical cases.  
 Stiffness changes of the TM were measured post-mortem in gerbils (Unge et al 
1999). With time, stiffness of the TM decreased, though the thickness of the TM 
increased. The cholesteatoma was formed alongside otitis media, so the nature of the 
increased thickness may be due to either (Guan and Gan, 2013). However, because the 
TM plays an important role in cholesteatoma, studying physiological and mechanical 
changes may assist in understanding the disease progression.   
 In looking at what they called bone remodeling, mice were used to study the 
effects of keratin and PMMA particles placed on the calvariae (Chole et al 2000). 
Though cholesteatoma was not developed using this method, there were similar 
reactions of the bone due to their methods. The osteoclasts began significantly altering 
the bony geometry, though the inoculants were no longer on the surface. This delivered 
a method to study the bone destruction without the disease build, possibly coexistent but 
separable. 
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 Tinling and Chole published a series of papers studying cholesteatoma in 
Gerbils (Tinlgling and Chole 2006a, 2006b, 2006c). First, they documented the 
migration pattern and rate in gerbils compared to that of humans and guinea pigs 
(2006a). Guinea pigs’ TM migration patterns had been studied due to their comparative 
size. However, after staining their TMs with ink blots, Tinling and Chole found the 
migration pattern of gerbils more closely resembled that of humans than guinea pigs. As 
such, their following papers are primarily focused on the gerbil. 
  As well as a similar TM migration patter, gerbils are known to spontaneously 
develop cholesteatomas. Cholesteatoma development and middle ear changes were thus 
studied in gerbils to determine the similarities and differences (Tinling and Chole 
2006b). Because of the rapid rate of development, cholesteatomas were noted to form 
within 24 hours of their insult to create the disease. In monitoring the animals, they 
noted the need for complete occlusion of the ear canal to form cholesteatomas. Though 
otitis media could form immediately, without complete separation, the animals were 
likely to recover rather than produce cholesteatomas. They believed that an alternate 
migration pattern or rate resulted in ear canal debris accumulation. If the canal was not 
able to clear, cholesteatomas were very likely to form.  
 In their final paper in the series, Tinling and Chole investigated keratinizing 
epithelium hyperproliferation to cholesteatoma formation (2006c). They induced 
cholesteatoma using ligation, eustachian tube cautery, or a combination of the two. One 
ear of the animals was left untreated to act as a control and the animals were graded for 
severity based on their Stage 1-5 system. 
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 Even by 2010, the pathogenesis of cholesteatoma has not been satisfactorily 
answered. To address aspects of its origin, male Mongolian gerbils with transplanted 
TMs from females were ligated (Yamamoto-Fukuda 2010). Their results showed that in 
the hybrid (transplanted) cases, proteins from the transplanted TM were found in the 
cholesteatomas. Their results strengthened arguments of a tympanic origin of 
cholesteatoma rather than a mucosal origin. However, their results may be model 
specific, though they were able to definitively show that the origin was from the 
tympanic membrane. 
 Sole cholesteatomas have been the focus thus far, though some work has been 
done to study infected cholesteatomas, which are more aggressive though rarer. Gerbils 
infected with P. aeruginosa developed severe cholesteatomas (Jung et al 2011). The 
cholesteatomas in these cases grew faster and showed a greater degree of destruction 
compared to classic cholesteatomas. Their research supports treating infection in 
cholesteatomas, though the cholesteatoma itself will not be affected. Preventing 
infection will prevent much greater bone destruction, leading to severe and irreparable 
complications.  
In a study that tested the retraction pocket theory, continuous negative pressure 
was applied to the middle ear of rats (Akyama 2014). With an understanding that 
middle ear pressure influences the structure and function of the TM, continuous 
negative pressure was applied in attempt to understand the effect on the pars flaccida. 
The results indicated thickening of the epithelium of the pars flaccida, which might 
accelerate epithelial proliferation and differentiation, a precursor to cholesteatoma. The 
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study then supports the retraction pocket theory as a possible mechanism of 
cholesteatoma formation, though no cholesteatomas were observed in this study. 
Choufani et al. ligated the external auditory duct of Mongolian gerbils to 
develop the disease (2017). Their method was surgically easy with high rates of success 
in creating the disease and used histochemistry to show the similarities and differences 
between their animal model and cholesteatomas found in humans. Their research 
emphasized the need for reliable animal models that replicate the humans, due to the 
lack of treatment apart from surgery. 
Significance and Aims of Study 
 Only a partial overview has been provided here. In the literature search, most 
research has studied the pathogenesis of the disease, the bone destruction, and different 
methods for creating animal models. As well, several classification and staging criteria 
have been developed, though widespread use of any single system has been limited in 
success.  
 Work has progressed in cholesteatoma imaging as discussed. As well, pre-
operative surgical planning is discussed throughout medical reports and literature. 
However, even comprehensive reports may leave out significant details of why surgery 
choices were made or even specifics of surgeries. There have been no animal models 
found that detail plans of pre-operative surgeries and the plans for intervention based on 
knowledge of the disease progression. A method for detailing surgical intervention 
plans based on disease severity and growth could be useful in translation to the clinical 
case.  
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 To my knowledge, there is no animal model that studies pre/post-operative 
hearing functions of the animals with cholesteatoma. After surgery, the middle ear is 
filled with a biocompatible pack to hold surgical reconstructions in place until fully 
healed. The hearing function cannot be assessed in the patient for six months. At this 
point secondary surgical invasion might be needed, either to clear out residual disease 
or to correct reconstruction errors. A method for post-operative surgical assessment is 
needed.   
 In this report, chinchillas were used to create a cholesteatoma animal model with 
varying levels of severity. Our animal model was used to establish pre-surgical 
assessment and planning, surgical techniques, and post-surgical analysis. This work 
provides a foundation for future research, explored in Chapter 5. 
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Chapter 2: Experiment Design – Creating the Disease 
Animal Model – Chinchilla 
 Chinchilla lanigera were chosen for this study. The study protocol was approved 
by the Institutional Animal Care and Use Committee of the University of Oklahoma and 
met the guidelines of the National Institutes of Health (NIH) and the US Department of 
Agriculture (USDA). Young chinchillas were obtained from Moulton Chinchilla Ranch 
(Chatfield, MN), all 2-3 years old.  
 Chinchillas were used specifically because of their unique ears. The bulla 
(middle ear cavity) sits on top of the animal head, providing immediate access for 
surgery. As well, the large and complex geometry of the bulla should give insight to 
how the disease progresses with time, including which structures are eroded and which 
are left behind. The size allows time to observe the changes in the disease over periods 
of time.  
Propylene Glycol Inoculation 
Cholesteatoma was established in chinchillas through administration of 
propylene glycol (PG) (Sigma Aldrich 99.9% PG) as reported by Vassalli et al. (1988), 
Huang et al. (1988), Masaki et al. (1988), Meyerhoff et al. (1990), Wright et al. (1991), 
and Schmidt and Hellstrom (1994). In these published papers, different PG 
concentrations of 10%, 50%, 60%, and 90% were used to examine the degree of 
cholesteatoma severity in damaging middle ear ossicular chain and TM and the success 
rate for cholesteatoma formation. 70% and 90% PG concentrations were chosen to build 
the cholesteatoma model and investigate the relation between the PG concentration and 
the degree of cholesteatoma severity (severe or very severe level). Hearing levels were 
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tested prior to inoculation, after the inoculation time course, and after surgical 
intervention.  
Inoculation Parameters – Time, Concentration, Location 
 Animals were divided into two groups based on PG concentration: 70% (N=9) 
and 90% (N=8). Of those, two animals from each concentration were inoculated for two 
weeks, and the remaining were inoculated for six weeks (N=7 (70%) and N=6 (90%)). 
Prior to inoculation, animals were heavily sedated with a ketamine/xylazine cocktail (35 
mg/kg ketamine and 7 mg/kg xylazine).  Injections were given intratympanic and 
monitored endoscopically. Figure 2 is an experimental schematic for the inoculation. 
Single insults were made to the inferior of the tympanic membrane. Injections were 
administered slowly to prevent rapid pressure build up and further damage the tympanic 
membrane. Animals inoculated for two weeks were given two 0.2 mL injections with a 
week between injections. Animals inoculated for 6 weeks were given three 0.2 mL 
injections with two days between injections.  
 Group 2 (n=4) were given two weeks to develop cholesteatoma, two at 70% and 
two at 90%. Animals were again heavily sedated with a ketamine/xylazine cocktail (35 
mg/kg ketamine and 7 mg/kg xylazine). Injections were administered intratympanic at 
the inferior of the tympanic membrane, similar to Group 1 (Figure 1). Two injections of 
1 mL each were given, with a week between injections. Figure 2 shows an endoscopic 
photograph of an injection.  
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Figure 3. Experiment schematic with the endoscope observing a single 
intratympanic-inferior insult with PG injection. Note that the pinna was intact in all 
injections, not reflected in the schematic. 
 
 
23 
 
Figure 4. Endoscope photograph of the injection method. Endoscope is equipped with 
a 30° lens.  
 In all injections, only one ear of the animals was inoculated and the other left as 
a control. Comparison of the disease state was then directly compared to the healthy ear 
of the animal at all stages in the disease growth.  
Inoculation Time Course – Endoscopic Observation 
 Direct visual confirmation of cholesteatoma formation was obtained with 
endoscopic photography following PG injections using a Styker® endoscope system 
(Stryker® HD 3-Chip Camera; Stryker® X8000 Light Source; Stryker® SDC Ultra). 
Endoscopic pictures were taken biweekly to assess growth of the disease, tympanic 
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membrane damage, and state of the animal overall.  Images of the healthy and diseased 
case were taken. 
Hearing Function Tests 
In cholesteatoma ears, wideband tympanometry (WBT) was used to measure 
middle ear transfer function. Auditory brainstem response (ABR) was used to determine 
the hearing threshold. 
Middle ear energy absorbance (EA) describes the sound power transmitted into the 
middle ear over a broad range of frequency. The EA data were used as a check of the 
TM integrity and normal function of the middle ear before inoculation, after the 
inoculation time course, and after recovery of the animal. The EA was measured with a 
WBT with Reflwin PC software. The ear canal entrance was sealed by inserting and 
holding the probe with tip by hand and pressing against the bony rim ear canal entrance. 
The EA was measured across 60 frequencies between 0.25 Hz and 8 kHz. For all 
frequencies, the applied ear canal air pressure swept from 200 to -300 daPA. The peak 
EA and its corresponding middle ear pressure (MEP) were recorded from the sweeps. 
ABR measurements were conducted before inoculation, after the inoculation time 
course, and after recovery using a TDT system III (Tucker-Davis Technologies, 
Alachua, FL). Briefly, under anesthesia, stainless steel needle electrodes were 
positioned subcutaneously at the vertex of the skull and ventrolateral surfaces of the ear, 
with a ground electrode placed in the rear leg. Tone burst stimuli of 1 ms rise/fall time 
at frequencies of 0.5, 1, 2, 4, 6, and 8 kHz were generated. The ABR waveforms were 
recorded in descending 5 dB SPL intervals from the maximum amplitude until no 
waveform could be visualized.  
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Surgery 
 Surgery was performed in a designated surgical suite in our lab to eradicate 
cholesteatoma. Animals were heavily sedated with a ketamine/xylazine cocktail (35 
mg/kg ketamine and 7 mg/kg xylazine) and booster doses as needed. Post hearing 
function tests, the surgical site was sterilized and surgery began. The purpose of the 
procedure is clean out the cholesteatoma from the middle ear cavity, assess the extent of 
damage, and repair the middle ear, if possible. A 3D printed prosthesis with TM graft 
was used to reconstruct the middle ear, though details of the prosthesis are not included. 
Future studies will focus on the prosthesis reconstruction.  
 Two primary directions in surgery were taken: transbullar and transmeatal. In 
the transbullar approach, the dorsal-superior of the bulla was breached to expose the 
superior growth of the cholesteatoma. Proceeding inferiorly, cholesteatoma was 
removed via scraping and suction. Several bony partitions were destroyed to access the 
disease. The surgery proceeded to the inferior of the bulla until there was clear visual of 
the eustachian tube. 
 The transmeatal approach accessed the middle ear through the ear canal. The ear 
canal was cleared of debris and disease until the location of the TM was reached. Often 
the TM could not be found, likely destroyed in the disease time course. To view the 
malleus-incus complex, stapes, and round window, the tympanomeatal flap was raised 
and the bony over hang excised with a curette. The malleus-incus complex was 
removed if found and the stapes and round window cleaned. A middle ear prosthesis 
can now be inserted. The TM was replaced with a facia graft and the tympanomeatal 
flap was lowered over it. The animal was then sutured and allowed to recover. 
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Post-Surgery Observation 
After surgery, animals were allowed to recover. Animals were then monitored for 
two weeks, checking for complications and reoccurrence. At the end of the two-week 
period, hearing function tests are conducted and animals euthanized under heavy 
sedation. 
Micro-Computed Tomography 
Micro-computed tomography (micro-CT) imaging was used post-recovery to 
determine the extent of structural damage and geometric changes in the bulla. Micro-CT 
images were taken at Southern Methodist University in Dallas, Texas with a resolution  
of 13.27 μm. Micro-CT images were captured after 2 weeks of recovery post-surgery.  
Histology 
The histologic images of chinchilla temporal bones/bullae will document the 
tissue and structural damages caused by the cholesteatoma. Procedures followed 
previously published methods (Jiang et al, 2016). Three animals were taken at mid time 
course at one week, four weeks, and six weeks for different severity level analysis based 
on time course. Two of the animals were taken from the 70% concentration group for 
the short and long durations, and one animal was taken from the 90% PG concentration 
for the medium length duration. 
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Chapter 3: Results – Success and Failures 
Post-Experiment Overview 
 Prior to inoculation, hearing function tests were administered to assess baseline 
hearing prior to disease onset. Chinchillas were inoculated PG concentrations of 70% 
(N=7) and 90% (N=6). Four animals, two at 70% and two at 90%, were inoculated for 
two weeks. These were injected twice with 0.2 mL PG with a week between injections. 
Two were euthanized early and used to develop surgical methods for mild and moderate 
disease cases. Nine animals were inoculated for six weeks. These were injected three 
times with 0.2 mL PG with two days between injections. Of the six-week animals, three 
were euthanized early after one week, two weeks, and four weeks for histology, and 
four were euthanized early and used to develop surgical methods for severe disease 
cases.  Four animals were used for survival surgery: two after two weeks and two after 
six, with both groups made up of half 70% PG and 90% PG. 
Disease Development 
 Cholesteatoma formation was monitored endoscopically biweekly. Photographs 
of the disease were taken and the health of the animal was cataloged. Figures 3-5 show 
the disease progression. Figure 4 is a pretreatment photograph, taken immediately 
before injection. Figure54 is a photograph of disease progression one week after 
inoculation. The TM has discolored to a yellow near the annulus, and the TM has lost 
integrity in it structure, displaying several wrinkles in the surface. Yellow fluid can also 
be seen behind the TM. Figure 6 is a photograph typical of the cholesteatoma animals in 
this study. After two weeks, keratinizing debris fills the ear canal and the TM is no 
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longer observable. To not disturb the disease progression, the debris was left in the ear 
canal of animals until surgery.  
 
Figure 5. Healthy chinchilla tympanic membrane from Group 2 captured 
immediately before inoculation. 
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Figure 6. TM of the same chinchilla as in Fig. 3 from Group 2. Photo was taken 1 
week after the first inoculation.  
 
Figure 7. Ear canal of animal shown in Fig. 3. Ear canal has filled with keratin 
debris. The photo was taken two weeks from the first inoculation.  
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Surgery and Post-Surgery Observations 
Four animals underwent endoscopic surgery. Two animals were inoculated for 
six weeks, with PG concentration levels of 70 and 90%. Two animals were inoculated 
for two weeks, with PG concentrations at 90%. Table 1 summarizes the experiment and 
surgical outcomes. 
 
 
 
Table 1. Experimental summary of animals and their surgical outcomes. 
Animal 
Number 
PG 
Concentration 
Total 
Volume 
Injected 
(mL) 
Time from 
First 
Inoculation 
Severity of 
Disease 
Experiment 
Endpoint 
17-3-6 70% 0.6 5 Severe Recovery 
17-3-12 90% 0.6 5 Severe 48 hours 
post-surgery 
17-4-9 90% 0.4 2 Moderate 2 weeks 
17-4-10 90% 0.4 2 Mild/Moderate Died during 
surgery 
 
 Animal 17-4-9 was the most successful surgically. Figures 7 through 14 are 
endoscopic photographs of the cholesteatoma growth throughout the bulla and how the 
disease was eradicated as discussed in Chapter 2.  
 A post-auricular incision centered over the prominence of dorsal bulla was made 
using a 10 scalpel blade. the incision was approximately 2 cm long and made 
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superficially to preserve the facia layer. A small amount of facia was harvested for a 
TM graft later. The periosteum was the incised and peeled back with a surgical “hoe” 
instrument to reveal the bony wall of the bulla. A bur hold was then made into the 
lateral and inferior quadrant of the bony plate over the dorsal bulla; penetration was 
minimized to preserve the bone. Iris scissors were used to cut the bone anteriorly and 
medially from the bur hole. The cut bone was then lifted as a flap (Fig. 7). The revealed 
white mass is the cholesteatoma immediately beneath the bony wall of the bulla.  
 
 
Figure 8. Dorsal bulla bone flap lifted from the remaining bulla bony shell. The large 
white space is the capsule of the cholesteatoma matrix.  
 
 What was possible to remove from here was suctioned out. Then, second hole 
was made over the mastoid portion of the bulla, just inferior to the bony buttress which 
partitions the dorsal form the mastoid bulla. Cuts were made extending inferiorly and 
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medially from the second bur hole to remove the bone flap. the bony buttress was then 
resected with scissors (though drilling may be better) to create a wider opening for the 
endoscope (Fig. 8).  
 
Figure 9. Exposure of mastoid and dorsal bulla sections the partition separating the 
two has been removed to further access the bulla. 
 The capsule of the cholesteatoma can now be fenestrated and the keratin 
contents evacuated. The cholesteatoma matrix must be dissected and peeled from the 
inner surfaces of the bulla, down to the level of the ossicles. Figure 9 shows an intact 
bony buttress immediately superior to the ossicular chain. This partition must be drilled 
through and outward to create a pathway to the anterior of the bulla. Care was taken not 
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to interact with the tympanic segment of the facial nerve, immediately medial to the 
partition.  
 
Figure 10.  Bony partition separating the dorsal part of the bulla from the medial part 
of the bulla, near the ossicles. 
 The malleus-incus complex integrity may now be assessed. If hypermobile, 
erosion is suggested to have occurred. Inspect the anterior bulla and locate the apex of 
the cochlea and the cochlear strut which extends anteriorly to the eustachian tube orifice 
(Fig. 10). If cholesteatoma extends to this region, a suction tube may reach most of its 
extent. Dissect any matrix from anterior to posterior. Cholesteatoma was cleared from 
the middle ear as much as possible while identifying the facial nerve, stapes, and using 
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a 30° endoscope to inspect the medial surface of the  tympanic membrane to confirm 
damage. 
 
Figure 11. Partition separating the dorsal part of the bulla from the medial part of the 
bulla has been drilled out. The cochlea can be seen on the right. 
 The transmeatal view was now taken and keratin debris was cleared from the ear 
canal. The transmeatal flap, attached to the posterior annulus of the TM/posterior TM 
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remnant, was incised to lift with a Rosen blade (Fig. 11). Once incised, the flap was 
lifted with any TM remnants to the inferior (Fig. 12).  
 
Figure 12. Transmeatel view of TM and bulla. The transmeatal flap has already been 
cut (the blood marks the outline).  
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 The stapes was not visible with the lifted flap, so posterior bony canal was 
partially removed using a curette (Fig. 12).  
 
Figure 13. Transmeatal view of TM and bulla. The transmeatal flap has been lifted 
and part of the bony partition has been cut away using a curette.  
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 With the stapes location revealed, clear out any remaining cholesteatoma matrix. 
Attach strut of prosthesis (not shown) to stapes head, and fix TM graft to facia tissue 
and TM remnants (Fig. 13). The facia tissue was placed such that the ear canal was 
sealed form the middle ear.  
 
Figure 14. Fascia graft from transmeatal view. 
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 With the TM graft and prosthesis now in place, the animal was sutured (Fig. 14) 
and then allowed to wake up.  
 
Figure 15. Sutured incision of dorsal bulla skin using buried technique. 
  
39 
Micro-Computed Tomography 
Micro-CT scans of one chinchilla (17-4-9) were taken post recovery. Figures 14, 
15, and 16 are micro-CT scans of the healthy bulla (left) and the diseased bulla (right). 
Figure 14 scans are located in the superior region of the bulla, above the ossicles. Heavy 
corrosion is visible in all areas of the diseased bulla (right). As well, the bulla has 
become slightly misshapen, due to the softening of the bulla bony wall. There also 
appears to be a near breach of the cranial wall. 
 Figure 15 shows scans located near the vertical middle of the bulla. Again, 
heavy corrosion is visible in the diseased bulla (right). The TM is missing, confirmed by 
surgery conducted previously. The stapes, however, is present in this image. During 
surgery, the stapes was unable to be located. This reflects the need for improved 
surgical handling of the diseased ears. The cochlea appears to have been breached by 
the disease. As such, even removing the disease and reconstructing the ear would have 
negligible effects on the hearing of this animal. Early intervention is key to saving and 
recovering lost hearing.  
Figure 16 shows scans located in the inferior of the bulla. The scans show some 
carrion and bone resorption. However, it is worthwhile to note that in most surgeries, 
actual cholesteatoma was not found in the inferior region. The disease resided in the ear 
canal and the superior of the bulla. In none of the animals did the disease progress 
inferiorly. Yet, from micro-CT scans, there is obvious corrosion. Cholesteatoma must 
therefore not necessarily need contact with the bony wall to induce bone resorption.  
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Histology 
Histology sections were made and imaged for three animals. Based on the time 
course, the animals correlate to mild, moderate, and severe cholesteatoma cases. Figure 
17 is a histological image an animal inoculated with 0.6 mL of 70% PG, after one week 
(Group 1). The bony wall (BW) is intact without destruction. The epithelium (EP) 
appears normal, though there does exist cholesteatoma. Keratin debris (K) has begun 
proliferating and has begun lining the bony wall. The middle ear cavity (MEC) remains 
mostly clear.  
 
Figure 19. Histological image of cholesteatoma animal after one week. Bony wall 
(BW); epithelium (EP); keratin (K); middle ear cavity (MEC). The degree of damage 
and proliferation corresponds to a mild cholesteatoma level.  
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 Figure 18 is a histological image made after four weeks from inoculation (90% 
PG, 0.6 mL). The bony wall has begun eroding, with protrusions into the bony layer and 
the surface of the bony wall resorbing into the epithelium. In this location keratin is not 
visible, though the epithelial layer has increased in thickness compared to Figure 17.  
 
Figure 20. Histological image of a cholesteatoma animal inoculated with 0.6 mL of 
90% PG for four weeks. The degree of damage and proliferation corresponds to a 
moderate cholesteatoma level. 
 Figure 19 is a histological image taken after six weeks from inoculation (70% 
PG, 0.6 mL). The bony wall has been severely degraded with full penetrations as many 
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locations. Keratin separates from the bony wall by a thin epithelial layer. The middle 
ear cavity has been largely filled with keratin within the cholesteatoma sack.   
 
Figure 21. Histological image of a cholesteatoma animal inoculated with 0.6 mL of 
70% PG for six weeks. The degree of damage and proliferation corresponds to a 
severe cholesteatoma level. 
Hearing Function Tests 
 
 WBT and ABR were conducted at all stages at only one animal, 17-4-9, having 
received 0.4 mL of 90% PG and inoculated for two weeks. This preliminary recovery 
response is primarily due to the undeveloped reconstruction technique, though the 
eradication was successful.  
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 Figure 20 is the WBT response pre-inoculation. There is a clear frequency-
absorbance response across all frequencies and there is a single pressure-energy 
absorbance response, corresponding to a normal TM and middle ear in chinchillas.  
 
Figure 22. Wideband tympanometry response of a healthy chinchilla, prior to 
inoculation. Frequency-absorbance (left) and pressure-absorbance (right) responses 
are typical of healthy chinchillas.  
 Figure 21 is the WBT measurements after inoculation. Prior to tests, the middle 
ear was cleared of obvious keratin debris to improve transmission. However, the TM, as 
observed later by endoscope, was completed destroyed, correlating to the poor response 
recorded. The middle ear transmission must therefore be considered largely 
dysfunctional.   
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Figure 23. Wideband tympanometry response of a post-inoculated animal, with 0.4 
mL of 90% PG after two weeks. Both the frequency-absorbance response and 
pressure-absorbance responses suggest a failed middle ear transfer function.  
 
 Figure 22 is the WBT response post operation, measured after two weeks of 
recovery from surgery. Still largely dysfunctional, there is some improvement from the 
pre-operational measurements. The frequency-absorbance curve shows reasonable 
response from 2-6 kHz and some response at .5 kHz. The pressure-absorbance curve 
does not appear to provide the single peak appreciated in Figure 20, though there is a 
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non-response, suggesting a middle ear transfer with imperfect sealing. The 
reconstructed TM must not have fully been taken by the ear canal.   
 
Figure 24. Wideband tympanometry post recovery in chinchillas, two weeks after 
surgical intervention. Frequency-absorbance and pressure-absorbance response 
suggest some recovery.   
 Figure 23 is the summary of ABR response measured before inoculation (red), 
after two weeks of inoculation (blue), and two weeks after surgical intervention (green). 
The pre-inoculation response is a reasonable response from a healthy chinchilla the pre-
surgery response shows increases of the ABR threshold at all frequencies, especially at 
the lower levels. The average threshold increase is 23 dB. After surgery and recovery 
hearing functions were tested again. There was an improvement at 2, 4, and 6 kHz of 5 
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dB, correlating to the improved WBT response shown between Figs 21 and 22. Overall, 
the ABR threshold did not improve considerably.   
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Figure 25. ABR threshold response for pre-inoculation, pre-surgical, and post-
recovery.  
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Chapter 4: Discussion – Developing a Criteria for Severity and 
Surgical Improvement 
Overview of Study 
 PG inoculation in chinchillas is a highly effective method for producing 
cholesteatoma. In high concentrations and volume, the PG can produce severe 
cholesteatoma growth in short periods of time. Part of the difficulty in this study was 
readjusting the time frame to accompany the rapid onset. Most animals rapidly 
developed complications in Group 1 including head tilts, ocular conjunctivitis, and in 
some cases seizures. Any animal that degraded to the point of extreme lethargy or 
developed any level of seizures was euthanized immediately, assessed by attending 
veterinarian. Group 2 developed complications but were limited and full studies were 
possible. 
All animals developed cholesteatomas in Group 1 and Group 2. There were no 
observable differences between 70% and 90% animals from endoscopic, histological, or 
micro-CT observations. The greatest contribution to the cholesteatoma development 
was the time factor and the deposited volume of PG. By controlling these two factors, 
cholesteatomas can be predictably and repeatedly induced in chinchillas.  
Surgical Procedures 
 In Chapter 2, detailed methods for surgical eradication of cholesteatoma were 
provided. Chapter 3 discussed and documented the actual procedure in an animal 
surgery. The surgical approach for chinchillas vastly differs from the human approach 
with the reasons obvious. However, the large volume of the chinchilla middle ear 
provides a unique view into progressive growth and destruction of the middle ear. 
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During the surgical procedures, it was apparent the cholesteatoma primarily 
progressed to the superior of the bulla. Septa of the bulla were necessarily removed to 
access pockets of cholesteatoma, especially in the severe cases. Because of the labyrinth 
middle ear cavity in chinchillas, removing all cholesteatoma is difficult. The odd 
geometry and many cavities enables the cholesteatoma to grow into pockets that are 
difficult to surgical reach. However, using endoscopic techniques, the methods outlined 
did prove to be successful without reoccurrence in the animal which recovered from 
surgery for two weeks. Extended studies on recovery will be necessary in future studies 
with reasons discussed in Chapter 5.    
Middle Ear Damage – Micro-Computed Tomographic and Histological 
Observations 
 Both micro-CT and histology provided unique observations of the integrity of 
the middle ear cavity. In the case of histology, direct comparison of proliferation and 
damage was possible. Micro-CT showed extensive damage to the bony wall and 
destruction of middle ear constructions in all section (Figs. 14, 15, and 16). The damage 
found in the superior region was typical and observable endoscopically. The thinning of 
the cranial bone separating the middle ear from the brain was a frequent complication in 
the diseased animals. A few severe cases from Group 1 had such extensive 
cholesteatomas and damage, only the dura remained to separate the brain and the 
middle ear. These animals had developed other serious complications and their studies 
were terminated premature. However, in these animals, the ossicles were frequently 
undamaged as was the inferior of the bulla. The cholesteatomas are more likely to 
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progress through the superior of the bulla than to advance upon the cochlea until late 
into the disease progression.  
 In the medial micro-CT section, many structures were found to be damaged and 
destroyed. Some of these structures, such as the bone of the ear canal, were destroyed 
during surgical intervention and reconstruction Surprising form the scans was the 
presence of the stapes. Thick mucosal lining in the middle ear, prevalent in most of the 
middle ear, made cleaning the cochlea difficult, due to sensitive and fragile structures 
needing to be left intact including the oval window and the round window membrane. 
As well, to not damage the cochlea shell, scraping had to be performed gently. The 
malleus-incus complex was removed during surgery, though they appeared intact.  
 In the inferior of the bulla, there was apparent damage observed in the scans, 
though the cholesteatoma sack was not found in any location below the TM. The 
mucosa had likely thickened as mentioned was found in other sections, though not 
obtrusively so. The bony degradation, therefore, could not be directly attributed to the 
cholesteatoma, corresponding to previous research suggesting that bone resorption does 
not need direct contact with cholesteatoma. 
 The graded destruction of the middle ear bony wall was determined primarily by 
the time course rather than the concentration (Figs 17-19). The histological images 
indicate that there is a time factor separating bone destruction and cholesteatoma 
contact/presence. After one week, cholesteatomas were produced. The rapid onset 
suggests the potency of the chemical inoculation. After four weeks, bone corrosion 
seems to have just begun, though this may not be typical. Some animals appear to have 
a greater accelerated cholesteatoma growth and this case could have been relatively 
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mild. Surgical intervention in the cases of these two cases is recommended with higher 
chance in hearing recovery.  
The six weeks case was typical, though. Apparent from the softened bulla, most 
animals by week six had developed extensive and highly destructive cholesteatomas. 
Surgical intervention in these cases would not restore hearing as the cochlea has been 
severely damaged; rather, only mitigating further destruction of the disease would be 
the goal.  
Proposed Levels of Severity – Rationale and Suggestions 
Though there are several methods for classifying cholesteatoma severity, our own 
method was developed for a few reasons. As will be discussed in Chapter 5, the primary 
purpose for this model is to maximize hearing recovery with complete disease 
eradication. The methods describe the extent of the disease growth in humans and the 
degree of proliferation to multiple section. Here, we expect the disease to growth and 
progress beyond its origin, though intervention success is still necessary to predict. 
Later, our classification may converge with published literature, but as our animal 
model develops, we have initiated with this current three-tier classification of its 
growth, based on histology, micro-CT, and endoscopic imaging. Table 2 illustrates the 
three-tier classification with endoscopic images. 
Mild cholesteatoma growth: This is the lowest classification for our animal model. 
Lower cases may be used, though future research will explore maximizing recovery 
under different damage levels. The matrix has covered the tympanic membrane or 
destroyed it. The matrix has begun growing toward the superior-dorsal space of the 
bulla. Adhering tissue is likely to be found covering the basal region of the cochlea. The 
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tympanic membrane and malleus incus complex must be replaced, though all the 
remaining structures should be able to remain. Reconstruction should be possible with 
significant hearing function regained.   
Moderate cholesteatoma growth: The matrix has filled the dorsal part of the bulla 
and the mastoid part of the bulla. The tympanic membrane has likely been destroyed. 
The malleus-incus complex has been dislodged from the stapes. The stapes may or may 
not remain attached to the oval window. The bulla cavity has been filled with keratin 
due to the cholesteatoma matrix. The bulla shell has likely begun to soften due to the 
erosion of the matrix. The matrix must be cleared from the bulla. Reconstruction is 
possible, thought regained hearing function will be limited to destruction. 
Severe cholesteatoma growth: Cholesteatoma matrix has filled the superior part of 
the bulla and eroded the septa. The bony wall between the bulla and the brain may have 
partially eroded. The labyrinthine of the bulla has partially been covered by the 
cholesteatoma matrix. The cochlea has begun to erode or has eroded in part. The incus-
malleus complex is likely dislodged and the tympanic membrane gone. The stapes may 
be dislodged if the basal part of the bulla remains intact. Most The bony wall protecting 
the facial nerve (N. VII) is partially or totally destroyed. The semicircular canals have 
mostly been eroded. Reconstruction is no longer possible aside from sealing the middle 
ear cavity from the atmosphere. Hearing function will not likely be regained.  
 
  
55 
T
a
b
le
 2
. 
S
u
g
g
e
st
e
d
 c
h
o
le
st
e
a
to
m
a
 c
la
ss
if
ic
a
ti
o
n
 f
o
r 
su
rg
ic
a
l 
in
te
rv
e
n
ti
o
n
. 
S
ev
er
e 
  
M
o
d
er
at
e 
  
M
il
d
 
  
L
o
ca
ti
o
n
 
S
u
p
er
io
r 
b
u
ll
a 
re
g
io
n
 
E
ar
 c
an
al
 
 
56 
Chapter 5: Future Studies 
A cholesteatoma animal model has been created using chemical injection of PG 
at varying concentration, time courses, and injection volumes. This model follows 
previous animal models though the research direction is vastly different. Using a three-
tiered classification based on endoscopic, histological, and micro-CT images, a surgical 
intervention assessment has been developed. Furthermore, surgical techniques for 
eradicating cholesteatoma from chinchillas has been described. Mild, moderate, and 
severe animal models have been shown and are repeatable depending on the 
aforementioned parameters. Though limited in use in the present study, this research has 
laid the foundation for future research in prosthetic design of clinical relevance. 
Fine-Tuned Cholesteatoma Development  
Based on our three-tier classification, this pilot study demonstrates that 
cholesteatoma may be produced in chinchillas both repeatedly and predictably. This is 
accomplished by varying time, injected PG volume, and PG concentration. The most 
critical of these parameters is time, as our method induces cholesteatomas rapidly, 
causing severe destruction the middle ear cavity. An interesting difference of our 
method is the lack of significant damage to the ossicles. In only the most severe cases 
was damage to the malleus-incus complex observed. The stapes appeared to be intact in 
all cases. However, the progression and damage to the bony wall is a useful parameter 
for reconstruction of the middle ear. As well, the TM was always irreparable except in 
the mild cases. As such, for TM reparation, intervention in this animal model must 
occur early in the cholesteatoma onset.   
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Middle Ear Prosthesis – Criteria, Design, Assessment 
Not mentioned was the methods used to reconstruct the middle ear in the 
chinchillas. The study has been preliminary in this regard, but this is a major and 
primary direction for future work. 3D printed middle ear prostheses will be used to 
study and maximize the hearing function in chinchillas. Normal materials cannot be 3D 
printed for biological use due to compatibility issues in long term studies. However, 
using finite element analysis, 3D printing technology for mold design or bio printed 
materials, and cellular seeding, reconstruction a patient specific ossicular replacement 
with tympanic membrane is possible.  
Middle Ear Post-Surgery Assessment 
Post-surgery assessment of middle ear reconstruction is made difficult by 
surgical techniques, fragility of the reconstruction, and time needed for surgery site to 
heal. In clinical settings, reconstruction is concluded by filling the middle ear with a 
biocompatible and degrading biogel. The biogel is inserted to stabilize the 
reconstruction of the ossicles until they have properly healed. Even when biogel is not 
needed, the reconstruction site is fragile. The implant and TM graft needs time to be 
accepted by the body and over stimulation may cause a disruption at some level, 
rendering the reconstruction ineffective. Methods for assessment and stabilizing will be 
further explored.  
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